Royal Bank Scotland Group Plc (RBS) 5.27 $RBS Downgrade

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Royal Bank Scotland Group Plc (RBS) 5.27 $RBS

Downgrade Alert for Royal Bank of Scotland (RBS)
Comtex SmarTrend(R) - Tue Sep 06, 3:01AM CDT
Royal Bank of Scotland (NYSE:RBS) was downgraded from Hold to Sell at Deutsche Bank today. The stock closed yesterday at $5.46 on volume of 1.4 million shares, above average daily volume of 1.0 million. In the past 52 weeks, shares of Royal Bank of Scotland have traded between a low of $3.91 and a high of $11.63 and closed yesterday at $5.46, which is 40% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.1% while the 50-day MA has declined 0.4%.
RBS: 5.27 (-0.19)

Scotia Bank's (BNS) Q3 Earnings Fail to Cheer Investors
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 7:54AM CDT
The Bank of Nova Scotia (BNS) lost nearly 1% on NYSE since the company declared its fiscal third-quarter 2016 (ended Jul 31) results on Tuesday, before the opening bell.
MTU: 5.49 (-0.15), DB: 14.46 (-0.44), RBS: 5.27 (-0.19), BNS: 54.95 (+0.62)

Bank of Montreal (BMO) Stock Up 2.9% as Q3 Earnings Rise
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
ADRs of Bank of Montreal (BMO) gained nearly 2.9% following the release of its third-quarter fiscal 2016 (ended Jul 31) results before the opening bell on Tuesday.
BMO: 67.45 (+0.39), DB: 14.46 (-0.44), RBS: 5.27 (-0.19), ITUB: 11.56 (+0.25)

How These Banking Stocks are Faring? -- Royal Bank of Scotland, HSBC Holdings, UBS Group, and East West Bancorp
PR Newswire - Wed Aug 24, 6:55AM CDT
Stocks in focus on Stock-Callers.com today belong to the Foreign Money Center Banking industry, which includes multinational financial institutions that service different countries around the world. The featured companies are: The Royal Bank of Scotland Group PLC (NYSE: RBS), HSBC Holdings PLC (NYSE: HSBC), UBS Group AG (NYSE: UBS), and East West Bancorp Inc. (NASDAQ: EWBC). Register now and get full and free access to our downloadable research reports on these stocks at:
EWBC: 36.49 (-0.97), HSBC: 38.33 (-0.32), UBS: 14.54 (-0.17), RBS: 5.27 (-0.19), WTBA: 19.58 (-0.03)

Banks, Brokerage Firms Sued for Australian Rate Rigging
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 11:02AM CDT
Major global banks and brokerage firms have been sued for alleged manipulation of the Australian benchmark rate.
WBK: 22.68 (+0.41), C: 47.29 (-0.22), CS: 13.15 (-0.12), HSBC: 38.33 (-0.32), DB: 14.46 (-0.44), UBS: 14.54 (-0.17), RBS: 5.27 (-0.19), MS: 31.75 (-0.14), JPM: 67.44 (-0.05), RY: 63.51 (+0.74), LYG: 3.17 (-0.14)

Barclays (BCS) Agrees to $100 Million Settlement over Interest Rate Manipulation
Afrasiab Mian - Zacks Investment Research - Mon Aug 08, 3:40PM CDT
On Monday, Barclays PLC (BCS) agreed to pay a $100 million settlement to 44 U.S. states after an investigation into manipulation of Libor (one of the most common benchmark interest rate indexes) by the firm.
BCS: 9.13 (-0.18), DB: 14.46 (-0.44), RBS: 5.27 (-0.19), UBS: 14.54 (-0.17)

Royal Bank of Scotland (RBS) Stock Down 5.93% on Q2 Loss
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:57AM CDT
Shares of The Royal Bank of Scotland Group plc (RBS) declined 5.93% on NYSE after it reported second-quarter 2016 loss attributable to its shareholders of ??1.08 billion ($1.55 billion).
DB: 14.46 (-0.44), RBS: 5.27 (-0.19), UBS: 14.54 (-0.17), ITUB: 11.56 (+0.25)

Itau Unibanco (ITUB): Dismal Q2 Earnings on High Expenses
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 2:06PM CDT
Brazil's Itau Unibanco Holding S.A. (ITUB) posted second-quarter 2016 recurring earnings of R$5.58 billion ($1.59 billion), down 9% year over year. Including non-recurring items, net income came in at R$5.52 billion ($1.57 billion), down 7.7% year over year.
DB: 14.46 (-0.44), RBS: 5.27 (-0.19), UBS: 14.54 (-0.17), ITUB: 11.56 (+0.25)

Mitsubishi UFJ's (MTU) Q1 Earnings Fall on Low Gross profits
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 2:27PM CDT
Mitsubishi UFJ Financial Group Inc. (MTU) reported profits attributable to owners of parent of ??188.9 billion ($1.75 billion) for the first quarter (ended Jun 30) of fiscal year ended Mar 31, 2017, down 32% year over year. http://www.mufg.jp/english/ir/fs/backnumber/2...1606_e.pdf http://www.mufg.jp/english/ir/fs/backnumber/2...1606_e.pdf http://www.mufg.jp/english/ir/fs/backnumber/2...1606_e.pdf http://www.mufg.jp/english/ir/fs/backnumber/2...1606_e.pdf Mitsubishi UFJ Financial Group Inc. (MTU) reported profits attributable to owners of parent of ??188.9 billion ($1.75 billion) for the first quarter (ended Jun 30) of fiscal year ended Mar 31, 2017, down 32% year over year.
MTU: 5.49 (-0.15), DB: 14.46 (-0.44), RBS: 5.27 (-0.19), UBS: 14.54 (-0.17)

Will Royal Bank of Scotland (RBS) Tank Post Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:15AM CDT
The Royal Bank of Scotland Group plc (RBS), set to release results on Friday, has lost more than 44% year to date on the NYSE
TD: 45.66 (+0.39), HSBC: 38.33 (-0.32), RBS: 5.27 (-0.19), CM: 80.75 (+0.49)

Deutsche Bank (DB) Misses Q2 Earnings on Low Revenue
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:30PM CDT
Deutsche Bank AG (DB) reported net income of EUR20 million ($22.6 million) in the second quarter of 2016, significantly down on a year-over-year basis. Income before income taxes came in at EUR408 million ($460.7 million), down 66.8% year over year.
DB: 14.46 (-0.44), RBS: 5.27 (-0.19), UBS: 14.54 (-0.17), ITUB: 11.56 (+0.25)

After Yesterday's Rally of 2.46% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 22, 2:00PM CDT
Royal Bank of Scotland (NYSE:RBS) traded in a range yesterday that spanned from a low of $7.24 to a high of $7.35. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $7.20 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RBS: 5.27 (-0.19)

RBS Plans 900 Layoffs as Cost Cutting Initiatives Continue
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 6:45AM CDT
The Royal Bank of Scotland Group plc (RBS) is likely to cut another 900 jobs as it continues with its aggressive cost cutting moves.
BCS: 9.13 (-0.18), HSBC: 38.33 (-0.32), RBS: 5.27 (-0.19), LYG: 3.17 (-0.14)

To Bet Against Brexit, Buy These 3 British Banking Stocks
Maher Syed - Zacks Investment Research - Tue Jun 21, 2:10PM CDT
You could wager on the vote itself, but this is a more prudent way to bet against Brexit.
BCS: 9.13 (-0.18), RBS: 5.27 (-0.19), LYG: 3.17 (-0.14)

Brexit: Britain's Newest Rollercoaster Ride
Afrasiab Mian - Zacks Investment Research - Mon Jun 20, 2:47PM CDT
Monday opened with a more bullish market due to polls from Britain showing an increase in support for remaining in the EU rather than exiting under Brexit.
BCS: 9.13 (-0.18), RBS: 5.27 (-0.19), LYG: 3.17 (-0.14)

Foreign Money Center Banks Stocks Highlight - UBS Group, HSBC Holdings, The Royal Bank of Scotland Group, and East West Bancorp
PR Newswire - Fri Jun 10, 6:40AM CDT
On Thursday, June 09, 2016, the NASDAQ Composite ended the trading session at 4,958.62, down 0.32%; the Dow Jones Industrial Average edged 0.11% lower to finish at 17,985.19; and the S&P 500 closed at 2,115.48, down 0.17%. ActiveWallSt.com has initiated coverage on the following equities: UBS Group A.G. (NYSE: UBS), HSBC Holdings PLC (NYSE: HSBC), The Royal Bank of Scotland Group PLC (NYSE: RBS), and East West Bancorp Inc. (NASDAQ: EWBC). Learn more about these stocks by accessing their free trade alerts at:
EWBC: 36.49 (-0.97), HSBC: 38.33 (-0.32), RBS: 5.27 (-0.19), UBS: 14.54 (-0.17), WTBA: 19.58 (-0.03)

Royal Bank of Scotland Group Non-cumulative Dollar Preference Shares, Series R About To Put More Money In Your Pocket
PreferredStockChannel.com - Thu Jun 09, 12:40PM CDT
On 6/13/16, Royal Bank of Scotland Group plc's Non-cumulative Dollar Preference Shares, Series R will trade ex-dividend, for its quarterly dividend of $0.3828, payable on 6/30/16. As a percentage of RBS.
RBS: 5.27 (-0.19)

Canadian Imperial (CM): Q2 Earnings and Revenues Strong
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:14AM CDT
Canadian Imperial Bank of Commerce (CM) reported second-quarter fiscal 2016 earnings (ended Apr 30) on May 26. Adjusted earnings per share came in at C$2.40, up from C$2.28 in the prior-year quarter.
RY: 63.51 (+0.74), RBS: 5.27 (-0.19), UBS: 14.54 (-0.17), CM: 80.75 (+0.49)

RBS Eliminates 450 Jobs as Restructuring Continues
Zacks Equity Research - Zacks Investment Research - Tue May 31, 6:28AM CDT
The Royal Bank of Scotland Group plc (RBS) is reportedly eliminating 450 service jobs as it scales back operations to focus on retail and commercial banking business in the U.K.
BMO: 67.45 (+0.39), RBS: 5.27 (-0.19), ITUB: 11.56 (+0.25)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 3

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 6

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 3

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 4

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 4

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 4

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 1

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 1

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 0

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

Cardiovalve Targets CE Mark for Advanced Heart Valve Solutions

Updated Category News Views 402

Significant Milestone for Cardiovalve's Heart Valve Programs The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch Recently, Cardiovalve, a prominent player in transcatheter valve replacement technology, successfully completed patient enrollment for the groundbreaking Cardiovalve TARGET study focused on...

Continue Reading
Inflammatix Strengthens Leadership Team with New Executives

Updated Category News Views 190

Inflammatix Expands Leadership Team Inflammatix, a leader in molecular diagnostics, has made significant strides by adding three industry veterans to its executive leadership team. This strategic expansion is aimed at spearheading the commercialization of the company's flagship product, the TriVerity™ Test. The newly appointed executives include Dr. Sam Ajizian as Chief...

Continue Reading
Understanding Bitcoin Treasury Holdings and Market Impacts

Updated Category News Views 160

The Dynamics of Bitcoin and Treasury Companies In recent months, the activity surrounding Bitcoin has captured the financial world's attention, especially with treasury companies increasingly acquiring substantial amounts of BTC. However, despite this significant uptick in investment, the anticipated price escalation has not occurred as expected. Trends in Corporate...

Continue Reading
Trump Promises Legal Action Against Google if Elected

Updated Category News Views 108

Back in 2024, Donald Trump threw down the gauntlet on Google (NASDAQ: GOOGL) during a Truth Social update, claiming he'd go after them legally if he won the presidency. This wasn’t just some offhand comment; it was a calculated move that tied into his broader campaign strategy as he sought to rally his base around claims of media bias. Media Bias or Political Theater?...

Continue Reading
Upcoming Earnings Report Analysis for Asana (NYSE: ASAN)

Updated Category News Views 139

Asana's Earnings Preview Asana (NYSE: ASAN) is set to release its quarterly earnings report soon, generating anticipation among investors. Understanding the key insights prior to the announcement can be vital for making informed investment decisions. Analysts have estimated that the company could report an earnings per share (EPS) of $-0.03. The Market's Expectations...

Continue Reading